Disruption in combination inhaled corticosteroid therapy may lead to an increased rate of costly exacerbations and hospitalizations for Medicare patients
SAN ANTONIO, TX (October 1, 2018)- Disruption of the refill of patients' regular combination inhaled corticosteroid therapy brand may have impacted symptoms and disease control...







